文献速递心脏核医学放射性药物与辐射防护

非ST段抬高型急性冠脉综合征接受经皮冠状动脉介入治疗患者胸主动脉炎症与冠状动脉斑块易损特征的关系:一项FDG-正电子发射断层显像与光学相干断层扫描研究

Relation between thoracic aortic inflammation and features of plaque vulnerability in the coronary tree in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention. An FDG-positron emission tomography and optical coherence tomography study.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2017-06-06

纳入30例连续接受经皮冠状动脉介入治疗的非ST段抬高型急性冠脉综合征患者,介入前完成三支血管光学相干断层扫描(OCT),出院前完成18F-FDG-PET。降主动脉TBRmax与富含脂质斑块数量相关(β=3.72;95%CI 1.14-6.30;p=0.006),CRP校正后仍相关(β=3.58;95%CI -0.91-6.25;p=0.01);主动脉FDG摄取与薄纤维帽粥样斑块数量无关。

要点

  • 降主动脉TBRmax与OCT检出的富含脂质斑块数量相关,CRP校正后仍显著。
  • 降主动脉TBRmean与富含脂质斑块数量相关(β=4.22;95%CI 0.05-8.39;p=0.047)。
  • 主动脉FDG摄取与薄纤维帽粥样斑块数量无关。

核心结论

  • 在首次非ST段抬高型急性冠脉综合征患者中,降主动脉18F-FDG摄取与OCT检出的含或不含巨噬细胞的富含脂质斑块数量相关,该关联可能独立于CRP值。

研究设计与样本

  • 研究纳入30例连续的非ST段抬高型急性冠脉综合征并接受经皮冠状动脉介入治疗的患者,平均年龄62岁,其中26例为男性。
  • 所有患者介入前完成三支血管OCT,出院前完成18F-FDG-PET,采用单变量及CRP校正线性回归分析易损特征与升主动脉和降主动脉18F-FDG摄取的关系。

主要发现

  • 单变量线性回归中,降主动脉TBRmean与富含脂质斑块数量相关(β=4.22;95%CI 0.05-8.39;p=0.047),降主动脉TBRmax亦相关(β=3.72;95%CI 1.14-6.30;p=0.006)。
  • 降主动脉TBRmax与含巨噬细胞的富含脂质斑块数量相关(β=2.40;95%CI 0.07-4.72;p=0.044)。
  • CRP校正后,降主动脉TBRmax与富含脂质斑块数量仍呈线性相关(β=3.58;95%CI -0.91-6.25;p=0.01)。
  • CRP校正后,降主动脉TBRmax与含巨噬细胞的富含脂质斑块数量呈趋于显著的关联(β=2.30;95%CI -0.11-4.71;p=0.06)。
  • CRP校正后,降主动脉活动切片数(TBRmax≥1.6)与富含脂质斑块数量呈线性相关(β=2.34;95%CI 0.22-4.47;p=0.031);主动脉FDG摄取与薄纤维帽粥样斑块数量无关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To evaluate the relationship between aortic inflammation as assessed by 18F-fluorodeoxyglucose-positron emission tomography (18F-FDG-PET) and features of plaque vulnerability as assessed by frequency domain-optical coherence tomography (FD-OCT). METHODS: We enrolled 30 consecutive non-ST-segment elevation acute coronary syndrome patients undergoing percutaneous coronary intervention. All patients underwent three-vessel OCT before intervention and 18F-FDG-PET before discharge. Univariable and C-reactive protein (CRP)-adjusted linear regression analyses were performed between features of vulnerability [namely:lipid-rich plaques with and without macrophages and thin cap fibroatheromas (TCFA)] and 18F-FDG uptake in both ascending (AA) and descending aorta (DA) [measured either as averaged mean and maximum target-to-blood ratio (TBR) or as active slices (TBRmax ≥ 1.6)]. RESULTS: Mean age was 62 years, and 26 patients were male. On univariable linear regression analysis TBRmean and TBRmax in DA was associated with the number of lipid-rich plaques (β = 4.22; 95%CI 0.05-8.39; p = 0.047 and β = 3.72; 95%CI 1.14-6.30; p = 0.006, respectively). TBRmax in DA was also associated with the number of lipid-rich plaques containing macrophages (β = 2.40; 95%CI 0.07-4.72; p = 0.044). A significant CRP adjusted linear association between the TBRmax in DA and the number of lipid-rich plaques was observed (CRP-adjusted β = 3.58; 95%CI -0.91-6.25; p = 0.01). TBRmax in DA showed a trend towards significant CRP-adjusted association with number of lipid-rich plaques with macrophages (CRP-adjusted β = 2.30; 95%CI -0.11-4.71; p = 0.06). We also observed a CRP-adjusted (β = 2.34; 95%CI 0.22-4.47; p = 0.031) linear association between the number of active slices in DA and the number of lipid-rich plaques. No relation was found between FDG uptake in the aorta and the number of TCFAs. CONCLUSIONS: In patients with first NSTEACS, 18F-FDG uptake in DA is correlated with the number of OCT detected lipid-rich plaques with or without macrophages. This association may be independent from CRP values.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Taglieri N, Nanni C, Ghetti G, et al. Relation between thoracic aortic inflammation and features of plaque vulnerability in the coronary tree in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention. An FDG-positron emission tomography and optical coherence tomography study. Eur J Nucl Med Mol Imaging. 2017. PMID: 28584972. doi:10.1007/s00259-017-3747-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。